Milestone Event Milestone Payments. For RCC (2nd line) For HCC (2nd line) Tier 1 Additional Indication Tier 2 Additional Indication Milestone #1: Initiation of first Phase 3 Clinical Trial n.a. n.a. $[ * ] $[ * ] Milestone #2: First MAA filing with the EMA n.a $10 million $[ * ] $[ * ] Milestone #3: First MAA Approval by EMA $60 million $40 million $[ * ] $[ * ] TOTAL $60 million $50 million $[ * ] $[ * ]
Appears in 2 contracts
Samples: Collaboration and License Agreement, Collaboration and License Agreement (Exelixis, Inc.)
Milestone Event Milestone Payments. For RCC (2nd line) For HCC (2nd line) Tier 1 Additional Indication Tier 2 Additional Indication Milestone #1: Initiation of first Phase 3 Clinical Trial n.a. n.a. $[ * ] 20 million $[ * ] Milestone #2: First MAA filing with the EMA n.a $10 million $[ * ] 25 million $[ * ] Milestone #3: First MAA Approval by EMA $60 million $40 million $[ * ] 50 million $[ * ] TOTAL $60 million $50 million $[ * ] 95 million $[ * ]
Appears in 1 contract
Samples: Collaboration and License Agreement (Exelixis, Inc.)
Milestone Event Milestone Payments. For RCC (2nd line) For HCC (2nd line) Tier 1 Additional Indication Tier 2 Additional Indication [ * ] [ * ] Milestone #1: Initiation of first Phase 3 Clinical Trial n.a. n.a. $[ * ] $[ * ] Milestone #2: First MAA filing with the EMA n.a $10 million $[ * ] $[ * ] Milestone #3: First MAA Approval by EMA $60 million $40 million $[ * ] $[ * ] TOTAL $60 million $50 million $[ * ] $[ * ]
Appears in 1 contract
Samples: Collaboration and License Agreement (Exelixis, Inc.)
